Article
Validation and evaluation of two porphobilinogen deaminase activity assays for diagnosis of acute intermittent porphyria.
Clinica chimica acta; international journal of clinical chemistry - 1 Apr 2018
Lin Chia-Ni, Huang Ya-Ching, Ro Long-Sun, Liao Ming-Feng, Ning Hsiao-Chen, Kuo Hung-Chou
Abstract excerpt
BACKGROUND: Acute intermittent porphyria (AIP) is caused by diminished activity of porphobilinogen deaminase (PBGD). The purpose of this study was to validate and compare two assays for PBGD activity. The clinical sensitivity of the PBGD activity assays in AIP diagnosis was also evaluated. METHODS: This study included 74 subjects from 18 Taiwanese families including symptomatic patients with AIP, asymptomatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
